The Downgrade Cliff: Forecasting RateGain's Reverse Trial Revenue Swing
Objective: Given a synthetic 90-day reverse trial cohort export (signups, premium feature touches, trial-end outcome), forecast the paid-conversion range and quarterly revenue delta a reverse trial produces versus RateGain's existing freemium baseline.
You're a growth analyst at RateGain Travel Technologies, the Noida-founded, NSE-listed travel-tech SaaS company, evaluating whether to convert 'RevGain Insights,' a premium demand-forecasting add-on for hotel revenue managers, from freemium to a 21-day reverse trial.
Use the trial cohort's feature-touch data to separate genuine forecast conversion from noise, then project the revenue delta against the freemium baseline.
Before you start
What you'll need
Free path (everything below is enough to finish)
Free, no account friction, sufficient for a 180-row segmentation and projection
The process
1 step
Step 01 of 01
The lesson's monetization-spectrum comparison shows freemium's core weakness is that users must pay before ever touching the premium value, which caps free-to-paid conversion far below what a reverse trial can reach once the same premium features are already integrated into a workflow.
Of 180 hotels on a 21-day RevGain Insights reverse trial, 62 used the demand-forecast export at least 3 times and 118 opened it once or never. Given the lesson's benchmark that repeated-touch trial users convert far above single-touch users, what paid-conversion range should you forecast for each group, and what does that imply for the freemium baseline RateGain already runs?
Procedure
- Import the cohort export and freeze the header row
- Segment rows into '3+ touches' (62 hotels) and '0-1 touches' (118 hotels)
- Apply the lesson's engaged-vs-unengaged conversion spread to each segment
- Multiply by RevGain Insights' ₹18,000/month list price to project quarterly revenue
- Compare the projected total against RateGain's existing freemium conversion baseline for the same 180 hotels
RevGain Insights, 21-day reverse trial cohort forecast 3+ TOUCHES (62 hotels) Forecast paid conversion: 30-34% Projected payers: ~19-21 hotels 0-1 TOUCHES (118 hotels) Forecast paid conversion: 5-7% Projected payers: ~6-8 hotels TOTAL PROJECTED PAYERS: ~25-29 of 180 (14-16%) FREEMIUM BASELINE (same 180 hotels, historical): 4% QUARTERLY REVENUE DELTA: +₹1.4M to +₹1.7M vs. freemium run rate
Healthy
Forecast conversion tracks feature-touch depth, with the 3+ touch segment projected several multiples above the freemium baseline.
Unhealthy
Treating all 180 trial hotels as one undifferentiated group and forecasting a single blended conversion rate off total signups.
What this means
Trial access alone doesn't predict conversion, repeated engagement with the specific premium feature during the trial does, so the forecast has to be built segment by segment.
So what do I do about it?
| Symptom | Action | Effort |
|---|---|---|
| Blended forecast undercounts the true opportunity from engaged trial users | Segment every reverse-trial forecast by in-trial feature-touch count before projecting revenue | 30 min |
| 0-1 touch segment still shows some conversion, diluting the model | Trigger a mid-trial nudge campaign at day 7 for hotels with zero feature touches | half day |
Final deliverable
A segmented conversion forecast (by feature-touch depth) with a projected quarterly revenue delta versus the freemium baseline.
See a reference example
Five-Star Business Finance, Q2 reverse trial forecast (excerpt) 3+ TOUCHES (41 branches) Forecast paid conversion: 28-32% Projected payers: ~11-13 branches 0-1 TOUCHES (76 branches) Forecast paid conversion: 4-6% Projected payers: ~3-5 branches QUARTERLY REVENUE DELTA: +₹8.6L to +₹10.2L vs. freemium run rate
Success criteria
You're done when you can:
- Correctly segments the cohort by feature-touch depth before forecasting
- Produces a quarterly revenue delta grounded in the segment-level conversion forecast, not a single blended rate